Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 7724297.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the cost-effectiveness of presumptive vaccination versus serological testing of school-age children (6 to 12 years) and adolescents (13 to 17 years) with a negative or uncertain history of varicella. Decision analysis model based on published and unpublished probabilities and costs. Hypothetical cohorts of 10,000 school-age children and 10,000 adolescents. Number of chicken pox cases prevented and cost per chicken pox case prevented. For school-age children, presumptively vaccinating would prevent 95% of the predicted chicken pox cases, would result in net savings when long-term and work loss costs were included, and would have a similar cost per case prevented as routinely testing before vaccination. For adolescents, presumptively vaccinating would be the most effective policy, and would prevent 99% of the projected chicken pox cases. A policy of routinely testing before vaccination would be the least effective policy for adolescents, preventing 81% of the predicted cases. However, even when long-term and work loss costs were taken into account, presumptively vaccinating adolescents had a relatively high cost of $329 per chicken pox case prevented and extremely high incremental costs per chicken pox case prevented compared with policies that involved serological testing. Results for school-age children were sensitive to the probability of previously having had chicken pox given a negative or uncertain history, to the rate of adherence to follow-up visits, and to vaccine price and test price. Results for adolescents were sensitive only to the rate of adherence to the first follow-up visit. Presumptively vaccinating all patients with a negative or uncertain history of varicella is projected to be a relatively cost-effective policy for school-age children but not for adolescents. However, further empirical studies of the accuracy of a negative or uncertain history of chicken pox in these age groups are needed.
Medical subject headings
- Chickenpox
- Decision Support Techniques
- Health Care Costs
- Immunization Programs
- Serologic Tests
- Vaccination